| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |